Kivorent News

Wednesday, November 18, 2026

Health techExplainer

What an FDA warning letter is, and what happens after one

An FDA warning letter tells a company the agency believes it is breaking the law and gives it a short window to fix things. Here is how letters work, what they cannot do, and why health app makers get them.

Docket, covering health regulation and AI in care
, 3 min read

15working days a company usually gets to respond

What to know

  • A warning letter is the FDA's formal notice that it considers a violation significant enough to lead to enforcement if not corrected.
  • The FDA treats warning letters as informal and advisory: they state the agency's view but are not a court order or a fine.
  • Letters are posted publicly on the FDA's website, and the agency can follow up with seizures, injunctions or civil penalties.

When the FDA decides a company is breaking the Federal Food, Drug, and Cosmetic Act in a way that matters, its usual first formal step is a warning letter. The letter names the product, lists the violations, and asks the company to say in writing how it will fix them. For makers of health apps and wearables, a letter is often the first sign that the agency sees their product as a medical device.

Where letters come from

Many warning letters follow an inspection. At the end of a visit, FDA investigators can hand the company a Form FDA 483, a list of what they observed, such as missing complaint records or untested software changes. If the company's response does not satisfy the agency, a warning letter may follow.

Others come from reading what a company says in public. For software, the FDA often looks at websites, app store listings and marketing claims. If a product is promoted to diagnose, treat or predict a disease and has no clearance or approval, the agency can say it is an unapproved device. That is the core of the FDA's 2025 letter to Whoop over its blood pressure estimates.

What the letter asks for

A warning letter typically:

  • Names the violations, such as a device sold without the required 510(k) clearance or premarket approval (PMA), false claims of FDA approval, or quality system failures.
  • Asks for a written response, usually within 15 working days, describing the corrections and steps to prevent a repeat.
  • Warns of consequences, stating that failure to correct the problems may lead to enforcement action without further notice.

For the differences between clearance, approval and De Novo, which come up in most device letters, see our explainer.

What a letter is not

The FDA's own procedures describe warning letters as informal and advisory. A letter communicates the agency's position, but it is not a final agency decision, a fine or a court order. A company can disagree, and some do in public. It can also fix the problems, change its claims, or file for clearance.

The agency also has a lower step, the untitled letter, used for violations it judges less serious. Untitled letters do not carry the same warning about enforcement.

Once the FDA confirms that a company has corrected the violations, often after a follow-up inspection, it can issue a close-out letter. That letter is posted too.

What can come next

If problems continue, the FDA can ask the Justice Department to seize products or seek a court injunction, pursue civil money penalties, or stop imported products at the border. Warning letters are also public: the FDA posts them on its website, with confidential details removed, so customers, investors and competitors can read them.

Why app makers get them

The line between a wellness product and a medical device depends on what the product does and what its maker says it does. The FDA's general wellness policy leaves low-risk products alone if they only support healthy habits. A feature that estimates a clinical measurement, flags a disease, or claims to predict a condition can cross that line. AI tools raise the same question; see when AI scribes count as devices.

Why it matters

A warning letter is the clearest public signal of where the FDA thinks a product has crossed from wellness into medicine. For readers, a posted letter is a reason to check what a product is actually cleared to do. For companies, it marks the point where the agency moves from guidance to enforcement.

This article is general information about how technology works. It is not medical advice. Talk to a clinician about your own health.

FDA and health regulationDigital health and AI in careWearables

Written by an AI correspondent under standards set by editor Jacob Knight. Spotted an error? Tell us and we will fix it.